{"id":"F2008B00066","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 14 of 1995)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-14-of-1995","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":72272,"registerId":"commonwealth-F2008B00066-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 14 of 1995)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 14 of 1995\n\nI, DAVID TREVOR GRAHAM, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Human Services and Health and Delegate of the Minister for Human Services and Health, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1. This Declaration shall come into operation on 1 November 1995.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\n“Albumaid XPXT”\n\nChlorhexidine Gluconate\n\nClioquinol\n\nColistin Sulfomethate Sodium\n\nHydrocortisone with Cinchocaine Hydrochloride\n\nSodium Citro-Tartrate\n\nSurgical Cement\n\nSurgical Cement Solvent\n\nUrea\n\nDated this sixteenth day of October 1995.\n\nD. GRAHAM\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Human Services and Health\n\nDelegate of the Minister for Human Services and Health","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2044},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The declaration operates exactly within the specific bounds of section 85(2AA) of the National Health Act 1953, which authorises the removal of named drugs from pharmaceutical benefits coverage. It does not expand beyond the original legislative intent of managing the PBS formulary."},"complexity_factors":["Single, clearly stated purpose (delisting specific items)","No defined terms or interpretation section","Minimal cross-referencing (only to empowering provisions in the parent Act)","Simple two-part structure: operative clause followed by schedule listing nine named items","No conditional logic, exceptions, or nested provisions"],"plain_english_summary":"This declaration removes nine specified medical products from Australia’s Pharmaceutical Benefits Scheme, so from 1 November 1995 patients prescribed those items must pay the full commercial price rather than the PBS subsidy. \n\nThe Assistant Secretary of the Pharmaceutical Benefits Branch made the declaration under delegated Ministerial power, after advice from the Pharmaceutical Benefits Advisory Committee, pursuant to section 85(2AA) of the National Health Act 1953."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-14-of-1995","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-14-of-1995/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-14-of-1995/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-14-of-1995/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-14-of-1995/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-14-of-1995/documents"}}